Global Biologics Market: Size, Trends & Forecast (2018-2022)

1
Global Biologics Market Size, Trends Forecasts
(2018-2022)

• February 2018

2
Global Biologics Market Coverage
3
Global Biologics Market Coverage
Scope of the Report
Attributes Details
Title Global Biologics Market Size, Trends Forecasts (2018-2022)
Coverage Global and Regional
Forecast Period of Market 2018-2022
Competition in the Market Dominated by top players.
Key Players Abbvie Inc., Samsung Electronics (Samsung Biologics), F. Hoffmann La Roche, and Amgen Inc.
4
Global Biologics Market
Executive Summary

• Pharmaceutical industry is engaged in the
  discovery, manufacturing and marketing of
  pharmaceutical drugs such as legal drugs,
  vaccines, biologics and a large number of medical
  devices such as infusion pump, pacemakers,
  prosthetics, implantable defibrillators etc.
  Pharmaceutical drugs and devices are subjected to
  various laws and regulations governing their
  patent, safety, and efficacy. On an elementary
  level pharmaceutical drugs are broadly classified
  into two categories small molecules
  (non-biologics) and large molecules (biologics).
• Large molecules are mostly made of cells or other
  living organisms and are used to produce
  therapeutic proteins or biological molecules.
  Drugs made up of large molecules are popularly
  known as biotech drugs, biologics or
  biopharmaceuticals. The major biologics
  blockbusters currently available in the market
  are Humira, Remicade, Enbrel, Avastin and
  Herceptin.
• The global biologics market has increased over
  the years and projections are made that the
  market would grow at a steady pace in the next
  four years i.e. 2018-2022, particularly due to
  increasing biologics approval and growing
  incidence of chronic conditions among the aging
  population. The global biologics market is
  supported by various growth drivers such as
  increased availability of advanced diagnostics,
  raising auto-immune diseases, higher usage of
  monoclonal antibodies for the treatment of
  different diseases, advancement in healthcare
  biotechnology, etc. Yet the market faces some
  challenges which are obstructing the growth of
  the market. Some of the major challenges faced by
  the industry are high cost of biologics, lack of
  oral absorption, complex regulatory approval etc.

5
Global Biologics Market
Market Overview
6
Pharmaceuticals Market Global Analysis
Global Pharmaceuticals Market by Value
2018-2022E (US Billion)
Global Pharmaceuticals Market by Segments 2017
Segments Share
Non-Biologics xx
Biologics xx
CAGR CAGR
2018-2022 xx
7
Biologics Market Global Analysis
Global Biologics Manufacturing Market by Value
2018-2022E (US Billion)
Global Biologics Market by Value 2018-2022E (US
Billion)
CAGR (2018-2022) CAGR (2018-2022)
Global Biologics Market by Value xx
Global Biologics Manufacturing Market by Value xx
8
Biologics Market Global Analysis
Global Biologics Market by Therapeutic Areas 2017
Global Biologics Market by Product-Category 2017
Therapeutic Areas Share Therapeutic Areas Share
Inflammatory xx Blood xx
Oncology and Immunomodulatory xx Cardiovascular xx
Endocrine xx CNS xx
Anti-infectives xx Sensory xx
Product-Category Share
Monoclonal Antibodies xx
Recombinant Proteins xx
Vaccines xx
Regenerative Medicines xx
9
Global Biologics Market Product Analysis
Global Biologics Monoclonal Antibodies Market by
Value
Global Biologics Recombinant Protein Market by
Value
Global Biologics Regenerative Medicines Market
by Value
Global Biologics Vaccines Market by Value
10
Global Biologics Market Therapeutic Areas
Analysis
Global Biologics Oncology and Immunomodulatory
Market by Value
Global Biologics Endocrine Market by Value
Global Biologics Inflammatory Market by Value
Global Biologics Anti-Infectives Medicines
Market by Value
11
Biologics Market Regional Analysis
North America Biologics Market by Value
Europe Biologics Market by Value
China Biologics Market by Value
Region CAGR (2018-2022)
North America xx
Europe xx
China xx
12
Biologics Market Dynamics
13
Biologics Market Competitive Landscape
Players Profiled

• Abbvie Inc.
• Samsung Electronics (Samsung Biologics)
• F. Hoffmann La Roche
• Amgen Inc.

14

• Title Global Biologics Market Size, Trends
  Forecast (2018-2022)
• Published Feb 2018
• Pages 91
• Price US 900 (Single-User License)
• US 1600 (Corporate License)
• For more info
• http//www.daedal-research.com/pharma-healthcare/g
  lobal-biologics-market-size-trends-forecast-2018-2
  022

For more details please contact Mr. Rajeev Kumar
Tel [phone] (9.30 am - 6.30 pm)
ISTMobile 91-9811715635 (24 X7)Enquiries
info_at_daedal-research.com
Daedal Research Daedal Research is a research and
consulting firm specialized in providing research
reports and customized business research and
analysis. The research firm offers a blend of the
best strategic consulting and market research
solutions, which promise data rich, cost
effective, and highly insightful analysis to help
its clients with perfect answers to their
important business queries.